Park-Hansen J, Greve AM, Clausen J, Holme SJ, Carranza CL, Irmukhamedov A, Sabah L, Lin Q, Madsen AS, Dom nguez H. New- onset of postoperative atrial fibrillation is likely to recur in the absence of other triggers. Ther Clin Risk Manag. 2018;14:1641 1647. doi: 444. Siu CW, Jim MH, Zhang X, Chan YH, Pong V, Kwok J, Kung AW, Lau CP, Tse HF. Comparison of atrial fibrillation recurrence rates after success- ful electrical cardioversion in patients with hyperthyroidism-induced ver- sus non-hyperthyroidism-induced persistent atrial fibrillation. Am J Cardiol. 445. Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, Camm AJ, Weitz JI, Lewis BS, Parkhomenko A, et al. Comparison of the efficacy and safety of new oral anticoagulants with war- farin in patients with atrial fibrillation: a meta-analysis of randomised trials. 446. Brembilla-Perrot B, Girerd N, Sellal JM, Olivier A, Manenti V, Villemin T, Beurrier D, DE Chillou C, Louis P, Selton O, et al. Risk of atrial fibrillation after atrial flutter ablation: impact of AF history, gender, and antiarrhyth- mic drug medication. J Cardiovasc Electrophysiol. 2014;25:813 820. doi: 447. Active Writing Group of the ACTIVE Investigators, Connolly S, Pogue J, Hart R, Pfeffer M, Hohnloser S, Chrolavicius S, Pfeffer M, Hohnloser S, Yusuf S. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibril- lation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for preven- tion of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet. 448. Jaillard A, Cornu C, Durieux A, Moulin T, Boutitie F, Lees KR, Hommel M. Hemorrhagic transformation in acute ischemic stroke: the MAST-E study: MAST-E group. Stroke. 1999;30:1326 1332. doi: 449. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, et al; on behalf of the American Heart Association Stroke Council. 